A global, multi-site observational clinical trial, a cross-sectional survey (paper) comparing women with and without an osteoporotic fracture (OF). Estimating Short-Term Indirect Cost and Physical Functioning Burden Associated with Osteoporotic Fractures.
Year: 2020
Type: Musculoskeletal
Phase: N/A
Indication: Osteoporosis
A First-in-Human Open-Label Phase 1/2a Study to Evaluate Safety, Tolerability and Efficacy of a Single Intra-Articular Injection of Allogeneic Mesenchymal Stem Cells Selected for Integrin α10β1 (XSTEM-OA) in Adult Patients with Symptomatic Knee Osteoarthritis.
Year: 2023
Type: Musculoskeletal
Phase: First-in-Human, I, IIa
Indication: Knee Osteoarthritis
A Multiple Arm, Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase 2 Study of Intra-Articular Administration of an Allogeneic Human Placental Tissue Particulate (PTP-001) for the Treatment of Knee Osteoarthritis.
Year: 2022
Type: Musculoskeletal
Phase: II
Indication: Knee Osteoarthritis
A 5-year, Randomized, Double-blind, Placebo-controlled, Multi-center Study Assessing the Efficacy, Safety, and Tolerability of Intra-articular Regimens of LNA043 Versus Placebo in Patients With Symptomatic Knee Osteoarthritis (ONWARDS).
Year: 2021
Type: Musculoskeletal
Phase: IIb
Indication: Knee Osteoarthritis
Upadacitinib treatment patterns, achievement of treatment targets and maintenance of response in moderate to severe Rheumatoid Arthritis patients in real-world practice (UPHOLD).
Year: 2020
Type: Musculoskeletal
Phase: Post-Market
Indication: Rheumatoid Arthritis
Real World Effectiveness of Upadacitinib on Early and Sustained Pain Control in Radiographic Axial Spondyloarthritis (UPSTAND).
Year: 2021
Type: Musculoskeletal
Phase: Post-Market
Indication: Spondyloarthritis
A Randomized, Active-Controlled, Parallel Group, Phase 3b/4 Study of Baricitinib in Patients with Rheumatoid Arthritis.
Year: 2021
Type: Musculoskeletal
Phase: IIIb, IV
Indication: Rheumatoid Arthritis
A Multicenter Open-Label Study Of Etanercept Withdrawal And Retreatment In Subjects With Non-Radiographic Axial Spondyloarthritis Who Achieved Adequate 24 Week Response.
Year: 2016
Type: Musculoskeletal
Phase: IV
Indication: Spondyloarthritis
A Phase 3b/4 Randomized Double-Blind Placebo Controlled Study Of Methotrexate (Mtx) Withdrawal In Subjects With Rheumatoid Arthritis (Ra) Treated With Tofacitinib 11mg Modified Release (Mr) Formulation.
Year: 2017
Type: Musculoskeletal
Phase: IIIb, IV
Indication: Rheumatoid Arthritis
A 12 Week Randomized, Double-Blind, Double Dummy, Parallel Group, Active And Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety Profile Of Pf-06650833 In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To Methotrexate.
